These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36637633)

  • 1. The long-term impacts of hearing loss, tinnitus and poor balance on the quality of life of people living with and beyond cancer after platinum-based chemotherapy: a literature review.
    Phillips OR; Baguley DM; Pearson SE; Akeroyd MA
    J Cancer Surviv; 2023 Feb; 17(1):40-58. PubMed ID: 36637633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer survivors treated with platinum-based chemotherapy affected by ototoxicity and the impact on quality of life: a narrative synthesis systematic review.
    Pearson SE; Taylor J; Patel P; Baguley DM
    Int J Audiol; 2019 Nov; 58(11):685-695. PubMed ID: 31545660
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of chemotherapy-induced inner ear damage on quality of life in cancer survivors: a qualitative study.
    Pearson SE; Caimino C; Shabbir M; Baguley DM
    J Cancer Surviv; 2022 Oct; 16(5):976-987. PubMed ID: 34398361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy.
    Sanchez VA; Dinh PC; Rooker J; Monahan PO; Althouse SK; Fung C; Sesso HD; Einhorn LH; Dolan ME; Frisina RD; Travis LB
    J Cancer Surviv; 2023 Feb; 17(1):27-39. PubMed ID: 36637632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platinum-induced hearing loss after treatment for childhood cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010181. PubMed ID: 27486906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2014 Jul; (7):CD009219. PubMed ID: 24984156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2012 May; (5):CD009219. PubMed ID: 22592737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of platinum-induced ototoxicity in pediatric patients in Quebec.
    Peleva E; Emami N; Alzahrani M; Bezdjian A; Gurberg J; Carret AS; Daniel SJ
    Pediatr Blood Cancer; 2014 Nov; 61(11):2012-7. PubMed ID: 24976616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study.
    Langer T; Clemens E; Broer L; Maier L; Uitterlinden AG; de Vries ACH; van Grotel M; Pluijm SFM; Binder H; Mayer B; von dem Knesebeck A; Byrne J; van Dulmen-den Broeder E; Crocco M; Grabow D; Kaatsch P; Kaiser M; Spix C; Kenborg L; Winther JF; Rechnitzer C; Hasle H; Kepak T; van der Kooi AF; Kremer LC; Kruseova J; Bielack S; Sorg B; Hecker-Nolting S; Kuehni CE; Ansari M; Kompis M; van der Pal H; Parfitt R; Deuster D; Matulat P; Tillmanns A; Tissing WJE; Beck JD; Elsner S; Am Zehnhoff-Dinnesen A; van den Heuvel-Eibrink MM; Zolk O;
    Eur J Cancer; 2020 Oct; 138():212-224. PubMed ID: 32905960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term auditory follow-up in the management of pediatric platinum-induced ototoxicity.
    Fetoni AR; Brigato F; De Corso E; Lucidi D; Sergi B; Scarano E; Galli J; Ruggiero A
    Eur Arch Otorhinolaryngol; 2022 Oct; 279(10):4677-4686. PubMed ID: 35024956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global burden of ototoxic hearing loss associated with platinum-based cancer treatment: A systematic review and meta-analysis.
    Dillard LK; Lopez-Perez L; Martinez RX; Fullerton AM; Chadha S; McMahon CM
    Cancer Epidemiol; 2022 Aug; 79():102203. PubMed ID: 35724557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different infusion durations for preventing platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2016 Aug; (8):CD010885. PubMed ID: 27498707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different infusion durations for preventing platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2014 Jun; (6):CD010885. PubMed ID: 24968257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ototoxicity monitoring in children treated with platinum chemotherapy.
    Brooks B; Knight K
    Int J Audiol; 2018 Sep; 57(sup4):S34-S40. PubMed ID: 28737048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Looking beyond the audiogram in ototoxicity associated with platinum-based chemotherapy.
    Baguley DM; Prayuenyong P
    Cancer Chemother Pharmacol; 2020 Feb; 85(2):245-250. PubMed ID: 31865419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platinum-induced ototoxicity: a review of prevailing ototoxicity criteria.
    Waissbluth S; Peleva E; Daniel SJ
    Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1187-1196. PubMed ID: 27245751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivors.
    Hjelle LV; Bremnes RM; Gundersen POM; Sprauten M; Brydøy M; Tandstad T; Wilsgaard T; Fosså SD; Oldenburg J; Haugnes HS
    Urol Oncol; 2016 Nov; 34(11):487.e13-487.e20. PubMed ID: 27523611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hearing loss after platinum treatment is irreversible in noncranial irradiated childhood cancer survivors.
    Clemens E; de Vries AC; Am Zehnhoff-Dinnesen A; Tissing WJ; Loonen JJ; Pluijm SF; van Dulmen-den Broeder E; Bresters D; Versluys B; Kremer LC; van der Pal HJ; Neggers SJ; van Grotel M; M van den Heuvel-Eibrink M
    Pediatr Hematol Oncol; 2017 Mar; 34(2):120-129. PubMed ID: 28590156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hearing impairment after platinum-based chemotherapy in childhood.
    Einar-Jon E; Trausti O; Asgeir H; Christian M; Thomas W; Måns M; Jon K; Hannes P
    Pediatr Blood Cancer; 2011 Apr; 56(4):631-7. PubMed ID: 21298751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors associated with cisplatin-induced ototoxicity in Japanese patients with solid tumors.
    Okada H; Kitagawa K
    Cancer Med; 2023 Apr; 12(7):7904-7910. PubMed ID: 36567514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.